نتایج جستجو برای: acute myeloid leukemia

تعداد نتایج: 704270  

Behjat Kalantarie Khandani Esmat Mozaffari Hamid Tabrizchi, Mahnaz Yazdanpanah

Myeloid sarcoma of female breast is a rare presentation of acute myeloid leukemia (AML). The tumor mass may precede or occur concurrently with AML, CML, myeloproliferative disorders, and/or myelodysplastic syndromes. Histologically, it looks like a large cell lymphoma and can be misdiagnosed. A case refe...

2007
Eric Scholar

Acute myeloid leukemia is not a single disease but a group of neoplastic disorders. The malignant cells gradually replace, and inhibit the growth and maturation of, normal erythroid, myeloid, and megakaryocytic precursors. Included among the names for this condition are acute myelogenous leukemia, acute myelocytic leukemia, acute myeloid leukemia, acute myeloblastic leukemia, acute granulocytic...

2011
Ulrike Bacher Claudia Haferlach Tamara Alpermann Wolfgang Kern Susanne Schnittger Torsten Haferlach

Background. The World Health Organization separates acute erythroid leukemia (erythropoiesis in ≥50% of nucleated bone marrow cells; ≥20% myeloblasts of non-erythroid cells) from other entities with increased erythropoiesis–acute myeloid leukemia with myelodysplasia-related changes (≥20% myeloblasts of all nucleated cells) or myelodysplastic syndromes, and subdivides acute erythroid leukemia in...

Journal: :journal of research in medical sciences 0
hossein ayatollahi mohammad hadi sadeghian mahmood naderi amir hossein jafarian seyyede fatemeh shams neda motamedirad

background: the wilms tumor 1 (wt1) gene is originally defined as a tumor suppressor gene and a transcription factor that overexpressed in leukemic cells. it is highly expressed in more than 80% of acute myeloid leukemia (aml) patients, both in bone marrow (bm) and in peripheral blood (pb), and it is used as a powerful and independent marker of minimal residual disease (mrd);we have determined ...

Journal: :Haematologica 2012
Aref Al-Kali Sergej Konoplev Erpei Lin Tapan Kadia Stefan Faderl Farhad Ravandi Mohamad Ayoubi Mark Brandt Jorge E Cortes Hagop Kantarjian Gautam Borthakur

BACKGROUND The hypocellular variant of acute myeloid leukemia accounts for less than 10% of all cases of adult acute myeloid leukemia. It is defined by having less than 20 percent of cellular bone marrow in a biopsy at presentation. It is unclear in the literature whether the outcome of hypocellular acute myeloid leukemia differs from that of non-hypocellular acute myeloid leukemia. DESIGN AN...

Background: Leukemia is one of the major causes of mortality and disability and the seventh most prevalent cancer worldwide. It has various effects on different aspects of physical, psychological, reproductive, social, and economic performance of human life. This study compared the quality of life of patients with different types of leukemia hospitalized in Ayatollah Khansari Hospital in Arak- ...

Journal: :Haematologica 2008
Brunangelo Falini Cristina Mecucci Giuseppe Saglio Francesco Lo Coco Daniela Diverio Patrick Brown Fabrizio Pane Marco Mancini Maria Paola Martelli Stefano Pileri Torsten Haferlach Claudia Haferlach Susanne Schnittger

Acute myeloid leukemia carrying NPM1 mutations and cytoplasmic nucleophosmin (NPMc(+) acute myeloid leukemia) represents one-third of adult AML (50-60% of all acute myeloid leukemia with normal karyotype) and shows distinct biological, pathological and clinical features. We confirm in 2562 patients with acute myeloid leukemia our previous observation that NPM1 mutations and cytoplasmic nucleoph...

MicroRNAs are small, non-coding sequences that regulate gene expression by inducing degradation or translational inhibition of target mRNAs. These molecules control many intracellular physiological and pathological processes.Abnormal expression of these moleculs has been described in different cancers including hematopoietic cancers. According to the type of cancer and the stage, miRNA’s expres...

Journal: :Haematologica 2011
Ulrike Bacher Claudia Haferlach Tamara Alpermann Wolfgang Kern Susanne Schnittger Torsten Haferlach

BACKGROUND The World Health Organization separates acute erythroid leukemia (erythropoiesis in ≥50% of nucleated bone marrow cells; ≥20% myeloblasts of non-erythroid cells) from other entities with increased erythropoiesis - acute myeloid leukemia with myelodysplasia-related changes (≥20% myeloblasts of all nucleated cells) or myelodysplastic syndromes - and subdivides acute erythroid leukemia ...

Journal: :Haematologica 2009
Xiao-Qian Xu Jian-Min Wang Shu-Qing Lü Li Chen Jian-Min Yang Wei-Ping Zhang Xian-Min Song Jun Hou Xiong Ni Hui-Ying Qiu

BACKGROUND Biphenotypic acute leukemia is a rare disorder that is difficult to diagnose. It displays features of both myeloid and lymphoid lineage. There is still a lack of studies in biphenotypic acute leukemia in a Chinese population. We present here a comprehensive investigation of the clinical and biological characteristics, and outcome of biphenotypic acute leukemia in our hospital in over...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید